Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Muscle Injury | Adult Stem Cell | Other Components | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Skeletal/Smooth Muscle disorders |
Embryonic Stem Cell, iPS Cell |
Exosomes based therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Salk |
![]() |
Development Candidate, Proof of Concept | |
Breast Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Cytonus Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Other | Adult Stem Cell | Protein/peptide therapy | Intact Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 2 | |
IPEX Syndrome | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Wounds, ulcers | Small molecule therapy | UCLA |
![]() |
IND | ||
Solid Tumors | Adult Stem Cell | Personalized cell therapy | BioEclipse Therapeutics INC. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Somatic Cell | Gene Therapy, cell free | Ray Therapeutics, INC |
![]() |
Pre-IND/IDE or Equivalent | |
Hypertension, pulmonary arterial | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Prostate Cancer | Gene-modified, personalized cell therapy | USC |
![]() |
Pre-IND/IDE or Equivalent | ||
Kidney Failure | Adult Stem Cell | Device | UC Davis |
![]() |
Pre-IND/IDE or Equivalent | |
Muscle Injury | Adult Stem Cell | Personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart failure | Gene Therapy, cell free | Tenaya Therapeutics, Inc. |
![]() |
Development Candidate | ||
Blood Disorders | Adult Stem Cell | Antibody | Stanford |
![]() |
Development Candidate | |
Alpha Thalassemia Major | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate | |
Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Epilepsy, Other |
iPS Cell | Gene Therapy, cell free | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Blood Disorders | Adult Stem Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
Intestinal Disease | iPS Cell | Exploring disease mechanisms | Cedars-Sinai |
![]() |
Proof of Concept, Tool/Resources/Bottleneck | |
Pancreatic Cancer | Cancer Stem Cell | Antibody | UCSD |
![]() |
Development Candidate | |
Leukemia | Cancer Stem Cell | Biologic | UCLA |
![]() |
Development Candidate | |
Alzheimer's Disease, Parkinson's Disease |
iPS Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
Autism, Epilepsy, Other |
iPS Cell | Nucleic acid based therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Vision Loss |
Embryonic Stem Cell, iPS Cell |
Gene Therapy, cell free | UCLA |
![]() |
Development Candidate, Proof of Concept | |
iPS Cell | Model system development | Nanotools Bioscience |
![]() |
Proof of Concept | ||
Type 1 diabetes |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Minutia, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate | |
Solid Tumors | Somatic Cell | Gene-modified, personalized cell therapy | UC Irvine |
![]() |
Development Candidate | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | Scintillon Inst |
![]() |
Development Candidate, Proof of Concept | |
Heart failure | iPS Cell | Nucleic acid based therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
Autism | iPS Cell | Donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Bladder or Urinary Tract Disorder | Somatic Cell | Tissue engineering | Wake Forest University Health Sciences |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
X-linked Chronic Granulomatous Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | ImmunoVec |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Gene Therapy, cell free | Excision BioTherapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | ||
Breast Cancer, Melanoma |
Somatic Cell | Donor cell therapy | Calidi Biotherapeutics, Inc. |
![]() |
IND | |
Brain Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Metabolic Disorders, Neurological Disorders |
Somatic Cell | Stanford |
![]() |
IND | ||
Anemia, Bone Marrow Transplant and Viral Infection |
Adult Stem Cell | Immune tolerance/management | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Colon Cancer | Tachyon Therapeutics, Inc |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |||
Neurological Disorders, Other |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Pre-IND/IDE or Equivalent | ||
Neurological Disorders | Gene Therapy, cell free | Mahzi Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | ||
Breast Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Other | iPS Cell | Model system development | Greenstone Biosciences |
![]() |
Tool/Resources/Bottleneck | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Neurological Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
IND |